ArticlePlastic and reconstructive surgery. Global open2024
A Novel Technique of Total Scrotal Resurfacing with NovoSorb Biodegradable Temporizing Matrix for Testicular Preservation.
Article in Plastic and reconstructive surgery. Global open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Use of NovoSorb Biodegradable Temporizing Matrix for Reconstruction of Scrotal Fournier Gangrene Wound.Plastic and reconstructive surgery. Global open · 2025Article
- NovosorbFrontiers in bioengineering and biotechnology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The reconstruction choice of scrotal defects after Fournier gangrene has been routinely based on the reconstructive ladder. Defects are usually managed with either skin-grafting or regional flaps to achieve testicular coverage. However, skin grafting done directly to testes may lead to chronic pain issues, and skin flaps can potentially be too thick to achieve good temperature control for spermatogenesis. We present the first reported case of total scrotal resurfacing after Fournier gangrene in a 48-year-old patient with NovoSorb Biodegradable Temporizing Matrix. The patient showed a good cosmetic outcome with no residual pain issues. Further research is recommended to further investigate the long-term effects of scrotal reconstruction with Biodegradable Temporizing Matrix.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.